NF-κB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia

Author： Breccia Massimo   Alimena Giuliana  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.11, 2010-11, pp. : 1157-1176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic targeting of NF-κB in myelodysplastic syndromes and acute myeloid leukaemia – the biological heterogeneity

By Bruserud Øystein   Reikvam Håkon  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. : 1139-1142

Informa Healthcare

Access to resources Recommend Favorite

NF-κB as a Therapeutic Target for Cardiovascular Disease

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 303-311

Karger

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite

Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes and Myeloid Leukemia

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 837-848

Bentham Science Publishers

Access to resources Recommend Favorite

NF-κB – a target in the inflammation of bone destruction

By Doggrell Sheila A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 191-193

Informa Healthcare

Access to resources Recommend Favorite